Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 Next >
Cramer's Lightning Round: Apple is a buy
Tags Mad Money S&P 500 T Rowe Price Group Inc
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Biotech and Pharmaceuticals Novo Nordisk A/S ETF Edge
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Eli Lilly and Co Health care industry Hospitals
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Healthy Returns Health care industry Science
From CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
Tags Medicine Business News Novo Nordisk A/S
From CNBC.com News
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
Tags Hims & Hers Health Inc Breaking News: Technology Health & Science
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health care industry
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health & Science
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Health care industry Eli Lilly and Co Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health & Science
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Amgen Inc
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Tags US: News Companies Biotechnology
From CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
Tags Health care industry Eli Lilly and Co Earnings
From CNBC.com News
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
Tags Earnings Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
Tags Biotechnology GSK plc AstraZeneca PLC
From CNBC.com News
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
Tags Congress Policy Health care industry
From CNBC.com News
More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
Tags Business News Health & Science Social issues
From CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
Tags Shake Shack Inc Starbucks Corp CAVA Group Inc
From CNBC.com News
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
Tags Business Pharmaceuticals Breaking news
From CNBC.com News
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
Tags Companies US: News Biotechnology
From CNBC.com News
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'
Tags US: News Business News Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
Tags Eli Lilly and Co Health care industry Healthy Returns
From CNBC.com News
Altimmune says weight loss drug minimized muscle loss in trial results that may set it apart
Tags Business Pharmaceuticals Science
From CNBC.com News
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health care industry
From CNBC.com News
Viking Therapeutics stock jumps 15% on promising weight loss pill data
Tags Business News Health & Science Biotechnology
From CNBC.com News
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
Tags Eli Lilly and Co Health care industry Novo Nordisk A/S
From CNBC.com News
Two fresh ways to play the weight loss and megacap tech hype
Tags Amazon/com Inc Artificial intelligence Markets
From CNBC.com News
Here's how much people are willing to spend on weight loss drugs, according to a new survey
Tags Eli Lilly and Co Health care industry Novo Nordisk A/S
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.